MedTrace Logo

IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.

NCT04402814 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2020-07-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate point of care SARS-Cov2 Virus IgG/IgM rapid test cassette Clungene test and correlate it with the standard method of testing in inpatients who have tested positive or negative for COVID19.

Conditions

  • SARS-CoV 2

Interventions

DIAGNOSTIC_TEST

Clungene rapid test cassette

Blood will be tested for the presence of IgG and IgM antibodies using the Clungene rapid test cassette.

Sponsors & Collaborators

  • Fadi Haddad, M.D.

    lead OTHER

Principal Investigators

  • Fadi Haddad, MD · Sharp HealthCare

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-05
Primary Completion
2020-10-01
Completion
2020-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04402814 on ClinicalTrials.gov